22 March 2024
Macaulay Capital
PLC
("Macaulay Capital" or the
"Company")
Final
Results
Macaulay Capital PLC (AQSE: MCAP), which was
formed to originate and manage corporate transactions, raise funds
from third parties, invest its own funds alongside those of
external investors and to manage its investment portfolio with the
aim of maximising its value, announces its final results for the
year ended 31 December 2023.
Copies of the annual report will be sent today to
shareholders along with the Notice of the Company's Annual General
Meeting which will take place on Friday 26 April 2024 at noon at 11
Laura Place, Bath, BA2 4BL.
This announcement contains inside information for
the purposes of the UK Market Abuse Regulation and the
Directors of the Company are responsible for the release of this
announcement.
Enquiries:
Macaulay Capital PLC
|
|
Clive Milner
|
+44 (0)20 3946 5980
|
|
|
Cairn Financial Advisers LLP (AQSE
Corporate Adviser)
|
|
James Caithie
Louise O'Driscoll
Emily Staples
|
+44 (0)20 7213 0880
|
|
|
Oberon Capital (Broker)
|
|
Chris Crawford
|
+44 (0)20
3179 5304
|
For more information please
visit: www.macaulaycapital.com
Chairman's Statement
Introduction
These accounts are the Company's first full year
accounts since its admission to trading on the Aquis Stock Exchange
Growth Market (AQSE) in July 2022, when we raised a total of £2
million before costs, at 20p per share.
As at 31 December 2023, the Group's net assets stood
at £1,361,811, which included investments valued at £900,000 and
cash of £338,484. In the year to 31 December 2023, our
revenues were £539,225, on which we incurred losses of
£76,195. Both our revenue and losses were better than budget,
principally due to performance fees we received on the successful
exit of one of our portfolio companies, Qualification Check Limited
("QCL"), to which I will return later. Although we expect to
incur losses while we build our business, we intend that, as a
trading business, we will in due course break even and then become
profitable.
The Horner Family increased its stake during the
year through a purchase of 200,000 shares at 22.5p per share in the
market and remains the largest shareholder block with a total of
2.3 million shares (23% of the Company's issued share capital),
which will increase by August 2024 by up to a further 6 million
shares, to 8.3 million shares (51.9%), through the exercise of
warrants priced at 25p per share.
Strategy
Our strategy is to build an investment origination
business focused on unquoted companies, generating fees
(transactions and ongoing) and investing alongside external
investors and management. We believe that private companies
represent an attractive asset class and, as the chart below shows,
the performance of private companies, as measured by the ten-year
time weighted rate of return, has been consistently stronger and
less volatile than that of public companies.
We target smaller private companies with an
enterprise value of £2-10 million, with proven businesses which
have established niches or developed other defensible qualities
that enable them to maintain and grow their activities over an
extended period of time. We are thus different from many
private equity funds which seek to invest in larger companies, in
high growth sectors often with novel or disruptive business
models.
In addition, because the sector that we target is of
less interest to many investors and thus less competitive, we are
able to structure investments at attractive valuations, typically
in a combination of redeemable loan stock and equity. This
means that investors can expect a yield on their investment, and
for most of their capital to be repaid over time, together with an
equity interest in the investee company. Also, because shares
in private companies benefit from Business Relief, investors will
be able to transfer their shares free of inheritance tax.
Our target market can be illustrated as shown
below:
Together with our co-investors, we provide a
combination of growth and replacement capital to investee
companies, which helps them to finance their future development as
well as facilitating partial exits for founder investors and
incentivising ongoing management through equity ownership. We
believe it important that, where we can, we co-invest alongside the
investors we introduce as this not only demonstrates our belief in
the investee companies but also aligns our interests with our
co-investors and the investee companies.
Portfolio
companies
We now have seven portfolio companies which includes
four previously managed by Chelverton Asset Management ("CAM", the
"Legacy Portfolio"). We identified the other three portfolio
companies - Vale Foods Holdings Limited, New Star Industries
Limited and Kelda Showers Limited and helped to agree the terms and
structure of the transactions as well as arranging some or all of
the investments.
Vale Foods Holdings Limited, which trades as
Devonvale, is a manufacturer of flapjacks, cakes and cereal bars
based in Honiton, Devon, and was our first investee company.
In May 2022, ahead of joining AQSE, we raised £1 million in a
combination of ordinary shares (£86,000 for 40% of the equity) and
unsecured loan notes (£914,000). Of the £1 million, we
invested £200,000, which includes an 8% equity interest. On 18
December 2023 we announced that we had provided Devonvale with
£125,000 of a £275,000 bridging loan that it took on in order to
finance new premises required to accommodate increased demand for
its products. We intend to refinance this loan by the end of
December 2024.
In March 2023 we undertook our second transaction.
New Star Industries Limited, which trades as Camloc, is an
established Midlands based precision engineering business which
manufactures compression struts and dampers. We invested £700,000
out of a total fund raising of £1.55 million, giving us a 23.8%
equity interest in the secondary buy-out from a private equity
fund. Whilst we intend to sell down £500,000 of this investment to
other investors in due course, 96.6% of it comprises 8% loan notes,
which means that while we continue to hold these loan notes we are
earning a significant revenue return on the investment.
In June 2023 we completed a transaction in relation
to Kelda Showers Limited ("Kelda"), a company which has developed a
disruptive water and energy-saving solution for the shower
market. We raised £940,000 from investors, including Kelda's
management and existing shareholders, but, on this occasion, the
Group did not itself invest as the investment was entirely in
ordinary shares that were expected to be eligible for EIS relief,
for which the Group is not eligible. The Group received an
arrangement fee of £47,000 in respect of the transaction however
and continues to receive an annual management fee from Kelda.
In addition to the above three companies, during the
year we managed an investment portfolio of five private companies,
(now four following the QCL exit), previously managed by CAM. Under
the agreements with the relevant companies, we are responsible for
monitoring their performance on behalf of investors previously
introduced by CAM. This includes a board position, for which
we are entitled to monthly management fees and potential
performance fees on exit.
QCL
QCL is a leading provider of global qualification
verification services. In August 2023, we announced that a
trade buyer had acquired all of the shares held by the B Share
Investors in QCL, who had been introduced by CAM. For those
who invested in February 2017, the sale price was a gross money
multiple return of 7.3 times, taking into account EIS relief, and
the gain is free of CGT. For those who invested in March 2021, the
sale price was a gross money multiple return of 3.8 times, before
CGT, and before management and performance fees payable on the
exit. The management and performance fees were shared
by Macaulay and CAM with the net amount received by Macaulay being
£211,751.
Investors
We believe that the area of the market that we
target for investment is underserved. This gives us the
opportunity to generate good returns for investors by identifying
established private companies at attractive valuations: the QCL
exit is an excellent example of what we are seeking to
achieve.
Whilst we believe it important that investors invest
across a range of our opportunities to reduce their investment
risk, we are confident that the potential for significant capital
returns and the fact that the equity is transferable free of
inheritance tax, should mean that our offering is of great interest
to High-Net-Worth individuals and Family Offices.
Accordingly, and as we have said previously, a
business imperative is to look for ways to broaden the pool of
potential investors for the investment opportunities that we
identify. This is where we are focusing our marketing
efforts.
Outlook
Whilst we did not introduce any new investments to
our investors in the second half of 2023, we have a number of
highly promising investment opportunities in our pipeline.
Our investment process is rigorous and time-consuming, and we are
highly selective, but we hope to bring some of these opportunities
to fruition in the first half of 2024.
Overall, we believe that we are on track and are
pleased with the progress that we have made to date and look
forward to the remainder of 2024.
Finally, and on behalf of the Board, I would like to
thank our Shareholders, employees, advisers and our co-investors
for their support.
Lindsay Mair
Chairman
21 March 2024
Consolidated
Statement of Comprehensive Income
for the Year Ended
31 December 2023
|
|
Year ended
|
Period ended
|
|
|
31 December
|
31 December
|
|
|
2023
|
2022
|
|
Notes
|
|
|
|
|
|
|
Income
|
4
|
539,225
|
118,737
|
Other expenses
|
5/6
|
(613,501)
|
(502,827)
|
Loss on ordinary
activities before interest and taxation
|
|
(74,276)
|
(384,090)
|
|
|
|
|
Interest
|
|
(1,919)
|
(904)
|
|
|
|
|
Loss on ordinary
activities before taxation
|
|
(76,195)
|
(384,994)
|
|
|
|
|
Taxation
|
7
|
-
|
-
|
Loss on ordinary
activities after taxation
|
|
(76,195)
|
(384,994)
|
|
|
|
|
Loss per Ordinary
share in pence
|
9
|
(0.76)p
|
(3.85)p
|
The notes form part of these
financial statements.
Consolidated Balance
Sheet
as at 31 December 2023
|
|
|
2023
|
|
2022
|
|
Notes
|
|
£
|
|
£
|
Fixed assets
|
|
|
|
|
|
Tangible assets
|
10
|
|
2,813
|
|
4,219
|
Investments at fair value through profit or loss
|
11
|
|
900,000
|
|
200,000
|
|
|
|
902,813
|
|
204,219
|
Current
assets
|
|
|
|
|
|
Debtors: amounts falling due within one year
|
13
|
175,503
|
|
104,962
|
|
Cash at bank and in hand
|
|
338,484
|
|
1,189,219
|
|
|
|
513,987
|
|
1,294,181
|
|
Creditors: amounts
falling due within one year
|
|
|
|
|
|
Other creditors and accruals
|
14
|
(54,989)
|
|
(60,394)
|
|
Net current
assets
|
|
|
458,998
|
|
1,233,787
|
Net assets
|
|
|
1,361,811
|
|
1,438,006
|
|
|
|
|
|
|
Capital and
reserves
|
|
|
|
|
|
Called up share capital
|
15
|
|
1,000,000
|
|
1,000,000
|
Share premium account
|
2.17
|
|
823,000
|
|
823,000
|
Profit and loss account
|
|
|
(461,189)
|
|
(384,994)
|
Shareholders'
funds
|
|
|
1,361,811
|
|
1,438,006
|
The financial statements were approved and
authorised for issue by the Board and were signed on its behalf on
21 March 2024.
Lindsay
Mair
Director
The notes form part of these
financial statements.
Company Balance Sheet
as
at 31 December 2023
|
|
|
2023
|
|
2022
|
|
Notes
|
|
£
|
|
£
|
Fixed assets
|
|
|
|
|
|
Investments in subsidiary
|
12
|
|
1,000,000
|
|
1,000,000
|
|
|
|
1,000,000
|
|
1,000,000
|
Current
assets
|
|
|
|
|
|
Debtors: amounts falling due within one year
|
13
|
323,408
|
|
28,517
|
|
Cash at bank and in hand
|
|
259,873
|
|
1,082,652
|
|
|
|
583,281
|
|
1,111,169
|
|
Creditors: amounts
falling due within one year
|
|
|
|
|
|
Other creditors and accruals
|
14
|
(34,944)
|
|
(390,814)
|
|
Net current
assets
|
|
|
548,337
|
|
720,355
|
Net assets
|
|
|
1,548,337
|
|
1,720,355
|
|
|
|
|
|
|
Capital and
reserves
|
|
|
|
|
|
Called up share capital
|
15
|
|
1,000,000
|
|
1,000,000
|
Share premium account
|
|
|
823,000
|
|
823,000
|
Profit and loss account
|
|
|
(274,663)
|
|
(102,645)
|
Equity
Shareholders' funds
|
|
|
1,548,337
|
|
1,720,355
|
The financial statements were approved and
authorised for issue by the Board on 21 March
2024 and were signed on its behalf by
Lindsay Mair
Director
The notes form part of these financial statements.
Consolidated Statement of Changes in Equity
for the Year Ended 31 December 2023
|
Called up
share capital
|
Share
premium
account
|
Profit and loss
account
|
Total
Equity
Shareholders'
Funds
|
£
|
£
|
£
|
£
|
At 1 January
2023
|
1,000,000
|
823,000
|
(384,994)
|
1,438,006
|
Total comprehensive
income for the period:
|
|
|
|
|
Loss for the period
|
-
|
-
|
(76,195)
|
(76,195)
|
At 31 December
2023
|
1,000,000
|
823,000
|
(461,189)
|
1,361,811
|
|
Called up
share capital
|
Share
premium
account
|
Profit and loss
account
|
Total
Equity
Shareholders'
Funds
|
£
|
£
|
£
|
£
|
At 13 May
2022
|
-
|
-
|
-
|
-
|
Total comprehensive
income for the period:
|
|
|
|
|
Loss for the period
|
-
|
-
|
(384,994)
|
(384,994)
|
Transactions with
Shareholders
recorded directly
to equity:
|
|
|
|
|
Issue of Ordinary shares
|
1,000,000
|
1,000,000
|
-
|
2,000,000
|
Expenses of share issue
|
-
|
(175,000)
|
-
|
(175,000)
|
Irrecoverable VAT on share issue expenses
|
-
|
(2,000)
|
-
|
(2,000)
|
At 31 December
2022
|
1,000,000
|
823,000
|
(384,994)
|
1,438,006
|
The notes form part of these
financial statements.
Company Statement of Changes in Equity
for the Year Ended 31 December 2023
|
Called up
share capital
|
Share
premium
account
|
Profit and loss account
|
Total
Equity
Shareholders'
Funds
|
£
|
£
|
£
|
£
|
At 1 January
2023
|
1,000,000
|
823,000
|
(102,645)
|
1,720,355
|
Total comprehensive
income for the period:
|
|
|
|
|
Loss for the period
|
-
|
-
|
(172,018)
|
(172,018)
|
At 31 December
2023
|
1,000,000
|
823,000
|
(274,663)
|
1,548,337
|
|
Called up
share
capital
|
Share
premium
account
|
Profit and loss account
|
Total
Equity
Shareholders'
Funds
|
£
|
£
|
£
|
£
|
At 13 May
2022
|
-
|
-
|
-
|
-
|
Total comprehensive
income for
the
period:
|
|
|
|
|
Loss for the period
|
-
|
-
|
(102,645)
|
(102,645)
|
|
|
|
|
|
Transactions with
Shareholders
recorded directly
to equity:
|
|
|
|
|
Issue of Ordinary shares
|
1,000,000
|
1,000,000
|
-
|
2,000,000
|
Expenses of share issue
|
-
|
(175,000)
|
-
|
(175,000)
|
Irrecoverable VAT on share issue expenses
|
-
|
(2,000)
|
-
|
(2,000)
|
At 31 December
2022
|
1,000,000
|
823,000
|
(102,645)
|
1,720,355
|
The notes form part of these
financial statements.
Consolidated Cash Flow
for the Year Ended 31 December 2023
|
|
2023
|
2022
|
|
|
£
|
£
|
Cash flows used in
operating activities:
|
|
|
|
Loss for the year
|
|
(76,195)
|
(384,994)
|
Adjusted
for:
|
|
|
|
Depreciation of assets
|
|
1,406
|
1,407
|
Interest paid
|
|
1,919
|
904
|
Increase in debtors
|
|
(70,541)
|
(104,962)
|
(Decrease)/increase in creditors
|
|
(5,405)
|
60,394
|
Net cash used in
operating activities
|
|
(148,816)
|
(427,251)
|
|
|
|
|
Cash used in
investing activities:
|
|
|
|
Purchase of investments
|
|
(700,000)
|
(200,000)
|
Purchase of fixed assets
|
|
-
|
(5,626)
|
Net cash used in
investing activities
|
|
(700,000)
|
(205,626)
|
|
|
|
|
Cash flows (used in)/
generated from financing activities:
|
|
|
|
Issue of Ordinary shares
|
|
-
|
2,000,000
|
Share issue expenses (including irrecoverable VAT)
|
|
-
|
(177,000)
|
Interest paid
|
|
(1,919)
|
(904)
|
Net cash (used in)/
generated from financing activities
|
|
(1,919)
|
1,822,096
|
|
|
|
|
Net
(decrease)/increase in cash and cash equivalents
|
|
(850,735)
|
1,189,219
|
|
|
|
|
Reconciliation of
net cash flow to movement in net cash:
|
|
|
|
(Decrease)/ increase in cash
|
|
(850,735)
|
1,189,219
|
Net cash at start of period
|
|
1,189,219
|
-
|
Net cash at end of period
|
|
338,484
|
1,189,219
|
The notes form part of these
financial statements.
.
Notes to the financial
statements
Year ended 31 December
2023
1 General information
Macaulay Capital Plc was
incorporated on 13 May 2022 for the purpose of acquiring Macaulay
Management Limited ("MML"). MML was incorporated on 14 October 2021
and was formed to originate and manage corporate transactions,
raise funds from third parties, invest the Group's own funds
alongside those of external investors and to manage the Group's
investment portfolio with the aim of maximising its value. Macaulay
Capital Plc acquired the entire issued share capital of MML on 14
June 2022.
The Company is a public limited company, which is
incorporated and registered in England and Wales (Registered
number: 14105915).
The registered office address is The Office Suite,
Den House, Den Promenade, Teignmouth, TQ14 8SY.
2 Accounting policies
2.1 Basis of preparation of financial statements
The
financial statements have been prepared under the historical cost
convention unless otherwise specified within these accounting
policies and in accordance with Financial Reporting Standard 102,
the Financial Reporting Standard applicable in the UK and the
Republic of Ireland and the Companies Act 2006.
The Company
has taken advantage of the exemption allowed under section 408 of
the Companies Act 2006 and has not presented its own statement of
comprehensive income in these financial statements.
The
preparation of financial statements in compliance with FRS 102
requires the use of certain critical accounting estimates. It also
requires management to exercise judgement in applying the Company's
accounting policies (see note 3).
The
following principal accounting policies have been applied:
2.2
Basis of consolidation
The consolidated financial statements incorporate
the results of the Company and its subsidiary MML, (together the
Group), as if they form a single entity using merger accounting. On
the establishment of the Company as the ultimate parent of the
Group, no change in ownership occurred and the entity was
established for the purpose of acquiring MML. Therefore, the
requirements of purchase method accounting did not
apply.
The
financial statements of the subsidiary are prepared for the year
ended 31 December 2023 using consistent accounting policies. All
inter-company balances and transactions, including unrealised
profits arising from them are eliminated on
consolidation.
2.3
Going concern
Company law requires the Directors
to consider the appropriateness of the going concern basis when
preparing the financial statements. At 31 December 2023, the Group
had cash balances of approximately £0.3 million and has access to
£1.5 million from the exercise of the Founder Warrants as detailed
in Note 15. Having reviewed cash flow forecasts for the period to
31 December 2025, the Directors confirm that they consider that the
going concern basis is appropriate. This review included
consideration of the Group's financial position in respect of its
cash flows and investment commitments (of which there are none of
significance), the working arrangements of key service providers,
the impact of the conflicts in Ukraine and the Middle East and the
current economic environment. In addition, the Directors are not
aware of any material uncertainties that may cast significant doubt
upon the Group's ability to continue as a going concern.
The Directors believe that the
Group has sufficient resources to continue in operational existence
for the foreseeable future. Thus, they have adopted the going
concern basis of accounting in preparing the annual financial
statements.
2.4
Revenue recognition
Income from arrangement fees is
recognised when the investment has been completed. Invoices for
monitoring fees are raised in line with each agreement. Fixed
returns on debt securities are recognised on a time-apportioned
basis so as to reflect the effective yield. Interest income is
recognised in the consolidated profit and loss account using the
effective interest method.
2.5
Income
Income is
attributable to the principal activities of the Group which are to
manage corporate transactions, raise funds from third parties,
invest the Group's own funds alongside those of external investors
and to manage the Group's investment portfolio.
All of the
reported revenue and operational results for the year derive from
the Group's principal activities and its investments and are
recognised on an accruals basis. The Group is not reliant on any
one customer.
2.6
Tangible fixed assets
Tangible fixed assets are stated at historical cost
less accumulated depreciation and any accumulated impairment
losses. Historical cost includes expenditure that is directly
attributable to bringing the asset to the location and condition
necessary for it to be capable of operating in the manner intended
by management.
Depreciation is charged so as to allocate the cost
of assets less their residual value over their estimated useful
lives, using the methods below:
Computer equipment - 4 years straight line.
2.7
Investment in subsidiaries
Investments in subsidiaries are measured at cost
less any accumulated impairment in value.
2.8
Financial instruments
The Group only enters into
basic financial instruments and transactions that result in the
recognition of financial assets and liabilities such as trade
debtors, investments and debt instruments and other debtors and
creditors. The Company has adopted section 11 of FRS 102 on the
recognition and measurement of financial instruments.
Financial assets that are measured at cost and
amortised cost are assessed at the end of each reporting period for
objective evidence of impairment. If objective evidence of
impairment is found, an impairment loss is recognised in the
statement of comprehensive income.
2.9
Investments
Investments are measured initially at cost and at
subsequent reporting dates at fair value and derecognised at the
trade date. Accordingly, as permitted by FRS 102, investments in
shares and loan notes upon their initial recognition are designated
as investments at fair value through profit or loss on the basis
that they qualify as a group of assets managed, and whose
performance is evaluated, on a fair value basis in accordance with
a documented investment strategy. Investments at fair value
through profit or loss are measured initially at transaction price
(not adjusted for transaction costs) and at subsequent reporting
dates at fair value. The changes in fair value of investments are
recognised in profit or loss and are treated as unrealised holding
gains or losses. Purchases and sales of investments are
recognised in the financial statements at the date of the
transaction (trade date).
2.10 Debtors
Short-term debtors are measured at transaction
price, less any impairment.
2.11
Cash and cash equivalents
Cash comprises cash at bank and
demand deposits. Cash equivalents are short-term, highly liquid
investments that are readily convertible to known amounts of cash
and which are subject to insignificant risk of changes in
value.
For the purpose of the Cash Flow
Statement, cash and cash equivalents consist of cash and cash
equivalents as defined above.
2.12
Creditors
Short-term creditors are measured at the transaction
price. Other financial liabilities,
should they arise, will be measured initially at fair value net of
transaction costs, and will be measured subsequently at amortised
cost using the effective interest method.
2.13
Pensions - contributory pension plan
The Group previously operated a contributory plan
for its employees. Once the contributions have been paid the
Group has no further payment
obligations.
In the previous period the contributions were
recognised as an expense in the profit and
loss account when they fell due. The current employees have opted
out of the Scheme and hence there is no charge in the profit and
loss account.
2.14
Earnings per share
Basic earnings per share is calculated by dividing
the profit or loss attributable to ordinary equity holders of the
Company by the weighted average number of ordinary shares
outstanding during the year.
Diluted earnings per share is calculated by
adjusting the earnings and number of shares for the effects of
dilutive options and other dilutive potential ordinary shares.
2.15
Dividend policy
The Company expects that returns to Shareholders
will be delivered primarily through an appreciation in the price of
the Ordinary Shares rather than by capital distribution through
regular dividends.
2.16 Current and
deferred taxation
The tax
expense for the year comprises current and deferred tax. Tax is
recognised in profit or loss except that a charge attributable to
an item of income and expense recognised as other comprehensive
income or to an item recognised directly in equity is also
recognised in other comprehensive income or directly in equity
respectively.
The current
income tax charge is calculated on the basis of tax rates and laws
that have been enacted or substantively enacted by the balance
sheet date in the countries where the Company operates and
generates income.
Deferred tax balances are recognised in respect of
all timing differences that have originated but not reversed by the
balance sheet date, except that:
• The
recognition of deferred tax assets is limited to the extent that it
is probable that they will be recovered against the reversal of
deferred tax liabilities or other future taxable profits;
• Where
they relate to timing differences in respect of interests in
subsidiaries and the Group can control the reversal of the timing
differences and such reversal is not considered probable in the
foreseeable future.
Deferred tax
balances are not recognised in respect of permanent differences
except in respect of business combinations, when deferred tax is
recognised on the differences between the fair values of assets
acquired and the future tax deductions available for them and the
differences between the fair values of liabilities acquired and the
amount that will be assessed for tax. Deferred tax is determined
using tax rates and laws that have been enacted or substantively
enacted by the balance sheet date.
2.17 Reserves
Share premium
account
The share
premium account represents the accumulated premium paid for shares
issued in previous periods above their nominal value less issue
expenses. This is a reserve forming part of non-distributable
reserves. The following items are taken to this reserve:
•
costs associated with the issue of equity; and
•
premium on the issue of shares.
Profit and
loss account
This reserve holds the accumulation
of profits and losses reduced by any dividends paid to
Shareholders.
3.
Judgements in applying accounting policies and key sources of
estimation uncertainty
The preparation of the financial statements requires
the Board to make judgements and estimates regarding the
application of policies and affecting the reported amounts of
assets, liabilities, income and expenses. Estimates and assumptions
mainly relate to the fair valuation of the fixed asset investments
particularly unquoted investments. Estimates are based on
historical experience and other assumptions that are considered
reasonable under the circumstances. The estimates and the
assumptions are under continuous review with particular attention
paid to the carrying value of the investments.
Investments at fair value through profit or loss are
regularly reviewed to ensure that the fair values are appropriately
stated. Unquoted investments in shares and loan notes are valued in
accordance with current International Private Equity and Venture
Capital Valuation (IPEVC) Valuation Guidelines, which can be found
on their website at www.privateequityvaluation.com,
although this does rely on subjective estimates such as appropriate
sector earnings or revenue multiples, forecast results of investee
companies, asset values of investee companies and liquidity or
marketability of the investments held.
4 Income
|
Year to
|
Period to
|
|
31
December 2023
|
31
December 2022
|
|
£
|
£
|
Arrangement fees
|
102,168
|
35,000
|
Monitoring fees
|
157,352
|
74,722
|
Loan note interest
|
56,717
|
9,015
|
Performance fees
received
|
211,751
|
-
|
Interest received
|
11,237
|
-
|
|
539,225
|
118,737
|
5 Other
expenses
|
Year to
|
Period to
|
|
31 December
2023
|
31 December
2022
|
|
£
|
£
|
Administration and secretarial
services
|
29,700
|
10,417
|
Auditor's remuneration
for:
|
|
|
-
Audit services
|
18,000
|
15,000
|
-
Non-audit services
|
-
|
6,319
|
Data and IT support
|
31,774
|
47,969
|
Legal & professional
fees
|
73,606
|
67,701
|
Irrecoverable VAT
|
24,709
|
15,897
|
Other expenses
|
84,152
|
51,658
|
|
261,941
|
214,961
|
The Audit fee paid by the Company
was £9,500 (2022: £9,500).
6 Directors' remuneration
and employee costs
|
Year ended
|
Period to
|
|
31
December 2023
|
31 December
2022
|
|
£
|
£
|
Directors' fees
|
165,666
|
88,449
|
Director's healthcare
|
8,618
|
459
|
Staff salaries
|
140,001
|
172,975
|
Pension contributions
|
-
|
2,345
|
Employer's national
insurance
|
37,275
|
23,638
|
|
351,560
|
287,866
|
The average number of employees for
the Group was 4 (2022: 4).
7
Taxation
|
Year to
|
Period to
|
|
31 December 2023
|
31 December 2022
|
|
£
|
£
|
Analysis of charge
in year
|
|
|
Current tax
|
-
|
-
|
|
-
|
-
|
Factors affecting
current tax charge for the year
The tax assessed for the year is lower than the
standard rate of corporation tax in the UK of 25% (2022:19%). The
differences are explained below:
|
Year to
|
Period to
|
|
31 December 2023
|
31 December 2022
|
|
£
|
£
|
Loss on ordinary activities
|
(76,195)
|
(384,994)
|
Theoretical tax at UK corporation tax rate of 23.52%
(2022:19%)
|
|
|
Corporation tax
|
(17,921)
|
(73,149)
|
Ineligible depreciation
|
331
|
267
|
Expenses not deductible for tax
purposes
|
-
|
-
|
Excess expenses for the
year
|
17,590
|
72,882
|
Current tax charge for the
year
|
-
|
-
|
Factors that may
affect future tax charges
At 31 December 2023 the Company had surplus
management expenses of £458,376 (2022: 383,587).
8
Parent company loss for the year
The Company has taken advantage of the exemption
allowed under section 408 of the Companies Act 2006 and has not
presented its own profit and loss account in these financial
statements. The loss after tax of the parent company for the year
was £172,018 (2022: £102,645).
9
Loss per share
The calculation of basic return per share is based
on the return after tax and on a weighted average number of
ordinary shares in issue in the period. Basic and diluted returns
per share are the same as there are no dilutive elements on share
capital.
|
Year to
|
Period to
|
|
31
December 2023
|
31
December 2022
|
Loss after taxation attributable
to Ordinary shareholders (£)
|
(76,195)
|
(384,994)
|
Weighted average Ordinary shares
in issue
|
10,000,000
|
10,000,000
|
Loss per Ordinary share - basic
and diluted (pence)
|
(0.76)
|
(3.85)
|
10
Tangible fixed assets
|
31 December
2023
|
31 December
2022
|
|
Group
|
Group
|
|
Computer
equipment
|
Computer
equipment
|
Cost or valuation
|
£
|
£
|
At 1 January 2023
|
5,626
|
-
|
Additions
|
-
|
5,626
|
At 31 December 2023
|
5,626
|
5,626
|
|
|
|
Depreciation
|
|
|
At 1 January 2023
|
1,407
|
-
|
Charge for the year
|
1,406
|
1,407
|
At 31 December 2023
|
2,813
|
1,407
|
|
|
|
Net book value at 31 December 2023
|
2,813
|
4,219
|
11 Investments
|
|
|
31
December
2023
|
31 December
2022
|
|
Investment in loan notes
|
Investment in unlisted shares
|
Total
|
Total
|
|
£
|
£
|
£
|
£
|
Investments held at fair value through profit or
loss
|
|
|
|
|
Opening book cost
|
182,800
|
17,200
|
200,000
|
-
|
Opening valuation
|
182,800
|
17,200
|
200,000
|
-
|
|
|
|
|
|
Movements in the year:
|
|
|
|
|
Purchases at cost
|
676,231
|
23,769
|
700,000
|
200,000
|
Closing valuation
|
859,031
|
40,969
|
900,000
|
200,000
|
|
|
|
|
|
Closing book cost
|
859,031
|
40,969
|
900,000
|
200,000
|
Closing valuation
|
859,031
|
40,969
|
900,000
|
200,000
|
|
|
|
|
|
On 20 May 2022, the Group invested in a company in
the bakery industry by purchasing 17,200 Ordinary B shares at £1
per share and issuing an unsecured loan note of £182,800 with
8% interest. Interest is received as it falls due every anniversary
date and the principal is to be repaid in full on 20 May
2027.
On 23 March 2023, the Group invested in an
engineering company by purchasing 23,769 Ordinary B shares at £1
per share and issuing an unsecured loan note of £676,231 with
8% interest. Interest is received as it falls due every anniversary
date and the principal is to be repaid in full on 20 May
2028.
The fair value of the investments is established by
using measures of value such as the price of recent transactions,
earnings or revenue multiples, discounted cash flows and net
assets. These are consistent with the IPEVC Valuation
Guidelines.
Investment in shares and loan notes were valued
using recent EBITDA information and relevant industry multiples,
where value deemed reasonable as compared to using industry EBITDA
multiple and net assets value approach.
At 31 December 31, 2023, the fair market value of
the investment in shares and loan notes approximated to its
carrying value.
12
Investment in subsidiary undertaking
|
31 December
2023
|
31 December
2022
|
|
Company
|
Company
|
|
£
|
£
|
At 1 January 2023
|
1,000,000
|
-
|
Additions
|
-
|
1,000,000
|
Carrying value at 31 December
2023
|
1,000,000
|
1,000,000
|
At 31 December 2023 the Company held interests in
the following subsidiary company
|
Country of
incorporation
|
% of capital
held
|
% share of voting
rights
|
Nature of
business
|
|
|
|
|
|
Macaulay Management
Limited
|
England
|
100%
|
100%
|
Investment company
|
The registered address of the subsidiary is the same as the
Company.
13
Debtors
|
Group
|
Company
|
|
31 December
2023
|
31 December
2023
|
|
£
|
£
|
Due
within one year:
|
|
|
Trade debtors
|
27,600
|
-
|
Other debtors
|
126,820
|
-
|
Amounts due from
subsidiary
|
-
|
314,316
|
Prepayments and accrued
income
|
21,083
|
9,092
|
|
175,503
|
323,408
|
|
|
|
|
|
|
|
Group
|
Company
|
|
31 December
2022
|
31 December
2022
|
|
£
|
£
|
Due within one year:
|
|
|
Trade debtors
|
58,781
|
-
|
Other debtors
|
31,920
|
23,949
|
Prepayments and accrued
income
|
14,261
|
4,568
|
|
104,962
|
28,517
|
14
Creditors amounts falling due within one
year
|
Group
|
Company
|
|
31 December
2023
|
31 December
2023
|
|
£
|
£
|
Trade creditors
|
7,377
|
4,607
|
Other taxation and social
security
|
11,389
|
6,624
|
Accruals and other
creditors
|
36,223
|
23,713
|
|
54,989
|
34,944
|
|
|
|
|
Group
|
Company
|
|
31 December
2022
|
31 December
2022
|
|
£
|
£
|
Amounts due to
subsidiary
|
-
|
350,908
|
Trade creditors
|
4,173
|
963
|
Other taxation and social
security
|
12,155
|
7,391
|
Accruals and other
creditors
|
44,066
|
31,552
|
|
60,394
|
390,814
|
15
Called up share capital
|
Group and
Company
|
|
31 December 2022 &
2023
|
Issued, allotted and fully paid:
|
Number
|
£
|
Ordinary shares of 10p
each
|
10,000,000
|
1,000,000
|
Ordinary shares have full voting rights with 1 vote
per share, they are entitled to dividends when proposed and are due
a capital distribution on a company exit event.
Share
options
The Company may adopt a formal incentive plan under
which it contemplates awarding Share Options to Directors,
employees and consultants pursuant to share option and incentive
schemes approved by the Board. It is intended that any individual
awards under any such scheme will be subject to vesting and/or
performance conditions. The proportion of Ordinary Shares which
will be made the subject of Share Options will not exceed 20 per
cent. of the Company's issued Ordinary Share capital from time to
time without the prior approval of the Shareholders and no Share
Options are intended to be granted to David Horner.
Founder
Warrants
Unconditional Founder Warrants have been issued to
subscribe for 6,000,000 Ordinary Shares exercisable at £0.25 per
share and which the Founder Warrant Holders have irrevocably
undertaken to exercise in full within two years of admission.
Conditional Founder Warrants have been issued to
subscribe for a further 5,000,000 Ordinary Shares, exercisable at
the higher of £0.25 per share or the mid- market price of an
Ordinary Share at the time of exercise, conditional on the exercise
of Share Options and in numbers of up to a maximum of (but not
exceeding) the numbers of Ordinary Shares issued following the
exercise of such Share Options.
16 Capital
commitments
At 31 December 2023 and 2022 there
were no capital commitments outstanding and no contingent
liabilities.
17
Directors' interests and related party transactions (Group and
Company)
The Company has taken advantage of
the exemption in section 33 of FRS 102 from the requirement to
disclose transactions with its wholly owned subsidiary on the
grounds that consolidated financial statements are prepared by the
Parent Company.
The Directors are considered to be
the key management of the business. Their remuneration for the year
is disclosed in note 6 of these financial statements.
The Directors and connected persons
held the following interests in the voting shares of the Company at
31 December 2023.
Number of shares
% of total voting rights
David
Horner
250,000
2.5%
Mary
Horner
50,000
0.5%
Lindsay
Mair
125,000
1.25%
For the purposes of the AQSE Growth Market Access
Rulebook the parties referred to below are related parties of the
Company for the reasons set out in those paragraphs.
David Horner is a related party of
the Company because he is a Director of the Company; and Mary
Horner, who is David Horner's wife, is for that reason an associate
of David Horner and thereby a related party to the
Company.
CAM, a company of which David
Horner is a director and significant shareholder, is a related
party of the Company because CAM is an associate of David
Horner.
Each of Harry and Tom Horner is a
related party of the Company for the following two
reasons:
each of them will be entitled to
exercise, or to control the exercise of, 10 per cent or more of the
votes able to be cast on all or substantially all matters at
general meetings of the Company; and each of them is a son of David
Horner and, as a result, an associate of his and therefore is a
related party.
Others
MML has taken over the investment
management of the unquoted investment portfolio of CAM, which David
Horner, a director of the Company, founded and of which he is
managing director. In line with its strategy, CAM's current and
future focus is on quoted companies, rather than unquoted
businesses, and therefore the unquoted portfolio is now
insignificant, relative to CAM's quoted company
portfolio.
In the year the Company's
operations manager has spent a proportion of his time working with
a private business owned by David Horner and his wife. Under
this agreement, the private business paid the Group £34,500 (2022:
£7,500), equivalent to the pro-rata cost of the operations
manager's employment to the Group.
18 Financial
instruments
The Group's financial instruments
comprise securities and other investments, cash balances and
debtors and creditors that arise from its operations, for example,
in respect of sales and purchases awaiting settlement and debtors
for accrued income.
The financial instruments of the
Group fall into the following categories:
Group
|
At
amortised
cost
|
Assets at fair value through
profit or loss
|
Total
|
31
December 2023
|
£
|
£
|
£
|
Assets as per the Balance Sheet
|
|
|
|
Investments
|
-
|
900,000
|
900,000
|
Debtors
|
152,600
|
-
|
152,600
|
Cash and cash equivalents
|
338,484
|
-
|
338,484
|
Total
|
491,084
|
900,000
|
1,391,084
|
|
|
|
|
Liabilities as per the Balance Sheet
|
|
|
|
Creditors
|
43,600
|
-
|
43,600
|
Total
|
43,600
|
-
|
43,600
|
|
|
|
|
|
|
|
|
Group
|
At
amortised
cost
|
Assets at fair value through
profit or loss
|
Total
|
31
December 2022
|
£
|
£
|
£
|
Assets as per the
Balance Sheet
|
|
|
|
Investments
|
-
|
200,000
|
200,000
|
Debtors
|
90,701
|
-
|
90,701
|
Cash and cash
equivalents
|
1,189,219
|
-
|
1,189,219
|
Total
|
1,279,920
|
200,000
|
1,479,920
|
|
|
|
|
Liabilities as per
the Balance Sheet
|
|
|
|
Creditors
|
48,239
|
-
|
48,239
|
Total
|
48,239
|
-
|
48,239
|
Company
|
At
amortised
cost
|
Assets at fair value through
profit or loss
|
Total
|
31
December 2023
|
£
|
£
|
£
|
Assets as per the balance sheet
|
|
|
|
Amounts due from
subsidiary
|
314,316
|
-
|
314,316
|
Cash and cash
equivalents
|
259,873
|
-
|
259,873
|
Total
|
574,189
|
-
|
574,189
|
|
|
|
|
Liabilities as per the balance sheet
|
|
|
|
Creditors
|
28,320
|
-
|
28,320
|
Total
|
28,320
|
-
|
28,320
|
|
|
|
|
Company
|
At
amortised
cost
|
Assets at fair value through
profit or loss
|
Total
|
31
December 2022
|
£
|
£
|
£
|
Assets as per the
balance sheet
|
|
|
|
Other debtors
|
23,949
|
|
23,949
|
Cash and cash
equivalents
|
1,082,652
|
-
|
1,082,652
|
Total
|
1,106,601
|
-
|
1,106,601
|
|
|
|
|
Liabilities as per
the balance sheet
|
|
|
|
Creditors
|
383,423
|
-
|
383,423
|
Total
|
383,423
|
-
|
383,423
|
|
|
|
|